Company Filing History:
2 out of 517 
2 out of 987 
Years Active: 2019-2024
Title: Mohammed Sardar: Innovator in Selectin Inhibitors
Introduction
Mohammed Sardar is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of selectin inhibitors. With a total of 2 patents, his work focuses on innovative solutions for anti-inflammatory and anti-thrombotic applications.
Latest Patents
Sardar's latest patents include advancements in selectin inhibitors, compositions, and their related uses. These disclosures detail glycopeptides that contain one or more modified amino acids conjugated to a saccharide or polysaccharide. The glycopeptides are designed for use as anti-inflammatory, anti-thrombotic, or anti-metastatic agents, showcasing the potential for significant medical applications.
Career Highlights
Throughout his career, Mohammed Sardar has worked with prestigious institutions such as Beth Israel Deaconess Medical Center and Emory University. His research has contributed to the understanding and development of therapeutic agents that target selectin pathways, which are crucial in various inflammatory and thrombotic conditions.
Collaborations
Sardar has collaborated with esteemed colleagues, including Richard D. Cummings and Elliot L. Chaikof. These partnerships have enhanced his research and expanded the impact of his innovations in the biomedical field.
Conclusion
In summary, Mohammed Sardar is a prominent inventor whose work on selectin inhibitors has the potential to advance medical treatments significantly. His contributions to the field reflect a commitment to innovation and collaboration in biomedical research.